https://metabolismnews.net/https://metabolismnews.net/_404.htmlhttps://metabolismnews.net/articolo/a-healthy-lifestyle-during-the-early-elderly-years-may-be-associated-with-exceptionally-long-lifehttps://metabolismnews.net/articolo/abdominal-obesity-may-be-reduced-by-y2r-inhibitorhttps://metabolismnews.net/articolo/acomplia-shows-modest-benefit-in-reducing-body-weighthttps://metabolismnews.net/articolo/alirocumab-as-add-on-to-atorvastatin-versus-other-lipid-treatment-strategieshttps://metabolismnews.net/articolo/alirocumab-reduces-ldl-cholesterol-in-familial-hypercholesterolemia-patientshttps://metabolismnews.net/articolo/annual-dose-of-zoledronic-acid-better-than-daily-bisphosphonates-at-improving-bone-densityhttps://metabolismnews.net/articolo/antioxidant-protective-effects-of-the-polyphenolic-egcg-in-green-teahttps://metabolismnews.net/articolo/biomarkers-of-longevity-prolonged-calorie-restriction-causes-a-reversalhttps://metabolismnews.net/articolo/black-americans-as-compared-with-whites-had-low-levels-of-total-25-hydroxyvitamin-d-and-vitamin-d-binding-proteinhttps://metabolismnews.net/articolo/calcium-and-vitamin-d-supplements-in-healthy-postmenopausal-women-provide-a-modest-benefit-in-preserving-bone-masshttps://metabolismnews.net/articolo/cardiovascular-benefit-safety-and-tolerability-of-extended-release-niacin-and-laropipranthttps://metabolismnews.net/articolo/cathepsin-k-inhibitors-odanacatib-increases-bone-mineral-density-following-prior-alendronate-treatment-in-post-menopausal-osteoporosishttps://metabolismnews.net/articolo/cetp-inhibitors-ta-8995-reduces-ldl-cholesterol-and-increases-cholesterol-effluxhttps://metabolismnews.net/articolo/cholesterol-lowering-drugs-reduction-of-cardiovascular-risk-adding-ezetimibe-to-simvastatin-in-high-risk-patients-with-acute-coronary-syndromehttps://metabolismnews.net/articolo/cholesterol-lowering-medication-evolocumab-a-pcsk9-inhibitor-safety-analysishttps://metabolismnews.net/articolo/consensus-panel-of-esa-homozygous-familial-hypercholesterolaemia-new-insights-and-guidance-for-clinicians-to-improve-detection-and-clinical-managementhttps://metabolismnews.net/articolo/critically-ill-patients-optimisation-of-energy-provision-with-supplemental-parenteral-nutritionhttps://metabolismnews.net/articolo/data-extension-study-two-years-of-denosumab-and-teriparatide-in-postmenopausal-women-with-osteoporosishttps://metabolismnews.net/articolo/diet-that-mimics-fasting-may-also-reduce-multiple-sclerosis-symptomshttps://metabolismnews.net/articolo/dieta-a-tappe-durante-la-chemioterapia-e-radioterapia-guida-completa-per-il-benesserehttps://metabolismnews.net/articolo/dietary-magnesium-associated-with-reduced-risk-of-heart-disease-stroke-and-type-2-diabetes-mellitushttps://metabolismnews.net/articolo/durable-and-potent-ldl-cholesterol-reduction-with-inclisiran-an-investigational-first-in-class-sirna-cholesterol-lowering-treatmenthttps://metabolismnews.net/articolo/dyslipidaemia-the-combination-of-statin-treatment-and-increased-fitness-resulted-in-substantially-lower-mortality-riskhttps://metabolismnews.net/articolo/ema-refused-of-the-marketing-authorisation-for-qsiva-a-drug-for-the-treatment-of-obesityhttps://metabolismnews.net/articolo/ema-refused-the-marketing-authorisation-for-kynamro-a-drug-for-treatment-of-patients-with-certain-forms-of-familial-hypercholesterolaemiahttps://metabolismnews.net/articolo/etc-1002-added-to-stable-statin-therapy-in-patients-with-hypercholesterolemia-etc-1002-009-trial-meets-primary-endpointhttps://metabolismnews.net/articolo/evolocumab-a-pcsk9-inhibitor-reduces-ldl-cholesterol-in-patients-with-heterozygous-familial-hypercholesterolemia-or-homozygous-familial-hypercholesterolemiahttps://metabolismnews.net/articolo/familial-hypercholesterolaemia-long-term-efficacy-and-safety-of-mipomersen-2-year-interim-resultshttps://metabolismnews.net/articolo/fosamax-may-be-linked-to-atrial-fibrillationhttps://metabolismnews.net/articolo/gastric-bypass-and-sleeve-gastrectomy-on-type-2-diabetes-mellitus-patients-with-bmi-less-than-30-kg-m2-abcd-score-can-predict-the-success-of-treatmenthttps://metabolismnews.net/articolo/gene-mutation-causes-lethally-low-fat-diethttps://metabolismnews.net/articolo/glagov-trial-lowering-ldl-cholesterol-with-evolocumab-a-pcsk9-inhibitor-impacts-underlying-atherosclerotic-disease-on-top-of-optimized-statin-therapyhttps://metabolismnews.net/articolo/glucocorticoid-induced-osteoporosis-teriparatide-more-effective-than-alendronatehttps://metabolismnews.net/articolo/gut-microbiota-derived-lipopolysaccharide-is-involved-in-the-development-of-obesityhttps://metabolismnews.net/articolo/hdl-cholesterol-efflux-capacity-inversely-associated-with-the-incidence-of-cardiovascular-eventshttps://metabolismnews.net/articolo/heterozygous-familial-hypercholesterolemia-63-of-patients-treated-with-alirocumab-no-longer-required-apheresishttps://metabolismnews.net/articolo/heterozygous-familial-hypercholesterolemia-individualized-low-density-lipoprotein-cholesterol-reduction-with-alirocumab-titration-strategyhttps://metabolismnews.net/articolo/high-cardiovascular-risk-patients-with-inadequately-controlled-hypercholesterolaemia-on-maximally-tolerated-doses-of-statins-efficacy-and-safety-of-alirocumab-versus-ezetimibehttps://metabolismnews.net/articolo/higher-death-rate-in-men-with-abdominal-fathttps://metabolismnews.net/articolo/higher-fracture-risk-linked-to-poor-persistence-with-osteoporosis-drugshttps://metabolismnews.net/articolo/higher-risk-of-dying-from-prostate-cancer-linked-to-excess-weight-and-adult-weight-gainhttps://metabolismnews.net/articolo/highest-risk-for-hip-fractures-for-older-womenhttps://metabolismnews.net/articolo/hps2-thrive-study-tredaptive-did-not-achieve-primary-endpointhttps://metabolismnews.net/articolo/humanized-monoclonal-antibodies-against-sclerostin-blosozumab-has-shown-anabolic-effects-on-bone-in-postmenopausal-womenhttps://metabolismnews.net/articolo/hypercholesterolemia-alirocumab-has-shown-a-62-reduction-in-ldl-c-compared-to-placebo-at-24-weeks-in-the-odyssey-long-term-trialhttps://metabolismnews.net/articolo/impact-of-obesity-on-the-kidney-function-morbid-obesity-interacts-with-type-2-diabetes-to-aggravate-uae-and-gfrhttps://metabolismnews.net/articolo/increased-risk-for-hip-fracture-associated-with-low-estrogen-levels-in-menhttps://metabolismnews.net/articolo/intensive-diet-and-exercise-program-can-prevent-knee-pain-among-overweight-adults-at-high-riskhttps://metabolismnews.net/articolo/ldl-cholesterol-level-lowering-alirocumab-more-efficacy-than-ezetimibe-in-patients-with-hypercholesterolemia-after-24-weekshttps://metabolismnews.net/articolo/lipoprotein-metabolism-plays-an-important-role-in-longevityhttps://metabolismnews.net/articolo/liver-signal-critical-for-insulins-brain-actionhttps://metabolismnews.net/articolo/long-term-mortality-non-fasting-ldl-cholesterol-has-similar-prognostic-value-as-that-of-fasting-ldl-cholesterolhttps://metabolismnews.net/articolo/long-term-obesity-is-associated-with-poorer-pancreatic-cancer-survivalhttps://metabolismnews.net/articolo/long-term-safety-and-efficacy-of-alirocumab-in-patients-with-heterozygous-familial-hypercholesterolemiahttps://metabolismnews.net/articolo/lower-rate-of-fractures-associated-with-exercise-in-elderly-womenhttps://metabolismnews.net/articolo/male-osteoporosis-safety-and-efficacy-of-actonelhttps://metabolismnews.net/articolo/management-of-hypercholesterolemia-mipomersen-is-a-promising-therapyhttps://metabolismnews.net/articolo/medications-associated-with-risk-of-developing-osteoporosishttps://metabolismnews.net/articolo/men-with-osteoporosis-at-high-risk-for-fracture-denosumab-for-the-treatment-of-bone-losshttps://metabolismnews.net/articolo/metabolic-disease-particularly-type-2-diabetes-mellitus-is-correlated-with-having-bacteria-that-penetrate-the-mucus-lining-of-the-colonhttps://metabolismnews.net/articolo/metabolic-syndrome-older-adults-may-reduce-risk-by-eating-more-whole-grainshttps://metabolismnews.net/articolo/microsomal-triglyceride-transfer-protein-inhibitors-efficacy-and-safety-of-lomitapide-in-patients-with-homozygous-familial-hypercholesterolaemiahttps://metabolismnews.net/articolo/mortality-of-severe-obesity-hypoventilation-syndrome-is-high-and-substantially-worse-than-that-of-obstructive-sleep-apneahttps://metabolismnews.net/articolo/niacin-therapy-is-associated-with-a-moderately-increased-risk-of-developing-diabetes-mellitushttps://metabolismnews.net/articolo/obese-patients-with-uncontrolled-type-2-diabetes-3-years-of-intensive-medical-therapy-plus-bariatric-surgeryhttps://metabolismnews.net/articolo/obesity-in-adolescents-significantly-increases-risk-of-heart-disease-regardless-of-ethnicityhttps://metabolismnews.net/articolo/obesity-may-be-caused-by-childhood-viral-infectionhttps://metabolismnews.net/articolo/obesity-may-be-factor-in-accelerated-type-1-diabetes-in-some-patientshttps://metabolismnews.net/articolo/odyssey-long-term-trial-robust-and-consistent-ldl-cholesterol-lowering-demonstrated-with-alirocumab-a-pcsk9-inhibitorhttps://metabolismnews.net/articolo/older-women-calcium-and-vitamin-d-slightly-decrease-risk-of-hip-fractureshttps://metabolismnews.net/articolo/osteoporosis-combination-therapy-of-anabolic-agents-and-bisphosphonates-improves-bone-mineral-densityhttps://metabolismnews.net/articolo/osteoporosis-teriparatide-not-cost-effective-compared-with-alendronatehttps://metabolismnews.net/articolo/patients-taking-high-dose-simvastatin-low-vitamin-d-as-a-risk-factor-for-the-development-of-myalgiahttps://metabolismnews.net/articolo/patients-with-hypertriglyceridemia-treated-with-akcea-apociii-lrx-have-experienced-dose-dependent-reductions-in-triglyceride-levels-apoc-iii-and-significant-reductions-in-atherogenic-lipoproteinshttps://metabolismnews.net/articolo/pcsk9-antibodies-safety-and-efficacy-of-alirocumab-and-evolocumabhttps://metabolismnews.net/articolo/pcsk9-inhibitors-alirocumab-monotherapy-reduced-ldl-cholesterol-three-times-more-than-ezetimibehttps://metabolismnews.net/articolo/pcsk9-inhibitors-spire-ai-study-evaluating-bococizumab-administered-with-pre-filled-pen-met-co-primary-endpointshttps://metabolismnews.net/articolo/poor-sleep-quality-may-be-associated-with-osteoporosishttps://metabolismnews.net/articolo/positive-results-from-rutherford-2-trial-of-evolocumab-in-patients-with-heterozygous-familial-hypercholesterolemiahttps://metabolismnews.net/articolo/postmenopausal-osteoporosis-denosumab-or-teriparatide-alone-or-combinedhttps://metabolismnews.net/articolo/postmenopausal-women-aged-80-years-or-older-with-osteoporosis-effects-of-abaloparatide-on-bone-mineral-density-and-risk-of-fracturehttps://metabolismnews.net/articolo/ppar-alpha-agonists-ly518674-shows-no-advantages-compared-with-fenofibratehttps://metabolismnews.net/articolo/premenopausal-women-assigned-to-follow-the-atkins-diet-for-one-year-lost-more-weight-compared-to-other-dietshttps://metabolismnews.net/articolo/prolia-increases-bone-density-cuts-fracture-risk-in-prostate-cancer-survivorshttps://metabolismnews.net/articolo/prolia-risk-of-hypocalcemia-osteonecrosis-of-the-jawhttps://metabolismnews.net/articolo/repatha-pushtronex-system-a-single-monthly-injection-for-pcsk9-inhibitor-approved-by-fdahttps://metabolismnews.net/articolo/rhizomelic-chondrodysplasia-punctata-a-rare-disorder-of-peroxisomal-metabolismhttps://metabolismnews.net/articolo/rna-interference-drug-on-the-synthesis-of-pcsk9-and-the-concentration-of-serum-ldl-cholesterol-in-healthy-volunteershttps://metabolismnews.net/articolo/romosozumab-shows-significant-increases-in-bone-mineral-density-at-both-spine-and-hip-in-postmenopausal-womenhttps://metabolismnews.net/articolo/saxenda-for-the-treatment-of-obesity-or-overweight-with-at-least-one-weight-related-comorbidityhttps://metabolismnews.net/articolo/statin-intolerant-patients-evolocumab-compared-to-ezetimibe-associated-with-significantly-greater-reduction-in-ldl-cholesterolhttps://metabolismnews.net/articolo/statin-treated-patients-with-hypercholesterolemia-bococizumab-a-monoclonal-antibody-directed-against-pcsk9-1https://metabolismnews.net/articolo/strong-association-between-25-oh-d-level-and-all-cause-and-cause-specific-mortalityhttps://metabolismnews.net/articolo/suspension-of-marketing-authorisation-for-acomplia-due-to-risks-of-psychiatric-reactionshttps://metabolismnews.net/articolo/teriparatide-increases-bone-mineral-density-in-men-with-glucocorticoid-induced-osteoporosishttps://metabolismnews.net/articolo/therapy-of-osteoporosis-an-updatehttps://metabolismnews.net/articolo/treatment-for-obesity-orlistat-lorcaserin-and-phentermine-plus-topiramate-linked-to-greater-mean-weight-loss-than-placebohttps://metabolismnews.net/articolo/treatment-with-vitamin-b12-and-folic-acid-linked-to-increased-risk-of-cancer-deathhttps://metabolismnews.net/articolo/use-of-vitamin-d-for-osteoporosis-prevention-in-adults-without-specific-risk-factors-for-vitamin-d-deficiency-seems-to-be-inappropriatehttps://metabolismnews.net/articolo/vitamin-d-for-osteoporosis-prevention-in-adults-without-specific-risk-factors-for-vitamin-d-deficiency-may-be-inappropriatehttps://metabolismnews.net/articolo/vitamin-d-supplementation-with-or-without-calcium-does-not-reduce-skeletal-or-non-skeletal-outcomes-by-more-than-15https://metabolismnews.net/articolo/weight-loss-low-carbohydrate-diets-appear-effectivehttps://metabolismnews.net/articolo/weight-management-in-adults-mysimba-in-addition-to-reduced-calorie-diet-and-physical-activity-recommended-for-approvalhttps://metabolismnews.net/articolo/withdrawal-of-the-marketing-authorisation-application-for-belviq-a-drug-for-helping-to-achieve-weight-control-in-obese-and-overweight-patientshttps://metabolismnews.net/articolo/wrist-circumference-is-a-practical-tool-for-assessment-of-metabolic-risk-in-overweight-obese-subjects-but-not-as-marker-of-advanced-atherosclerosishttps://metabolismnews.net/articolo/zoledronic-acid-an-osteoporosis-drug-risk-of-side-effects-not-significanthttps://metabolismnews.net/more/linkshttps://metabolismnews.net/page/1https://metabolismnews.net/page/2https://metabolismnews.net/page/3https://metabolismnews.net/page/4https://metabolismnews.net/page/5https://metabolismnews.net/page/6https://metabolismnews.net/page/7https://metabolismnews.net/page/8https://metabolismnews.net/page/9